The research team tested the therapy in a small group of 18 patients with recurrent glioblastoma in a phase 1 clinical trial, which primarily examines the treatment’s safety profile. Related Content.

Prompt Health, the AI-powered clinic operations platform built for rehab therapy, today announced its acquisition of PredictionHealth, creators of Sidekick, the popular AI scribe and coding assistant, ...

News24 brings you the top stories of the day, summarised into neat little packages. Read through quickly or listen to the articles via our customised text-to-speech feature.

Encompass Health Corporation EHC recently disclosed initial plans to construct a freestanding inpatient rehabilitation ...

Key TakeawaysThe global Anxiety Disorder Treatment Market is projected to grow from USD 12.7 billion in 2024 to USD 18.1 ...

The upcoming bill addressing Personal Independence Payment (PIP) reform and broader budget cuts could mark a turning point ...

Encompass Health Corp. (NYSE: EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation ...

South Gloucestershire Council’s assistive technology service, led by OTs and technicians, has successfully transformed adult social care ...

The chasm between policy formulation and on-the-ground action is glaring, leaving the disabled community sidelined, ...

Greys Anatomy and Euphoria Eric Dane has shared alarming news he is losing function in his body. This is what we know about ...

The report provides a detailed analysis of the current spinocerebellar ataxia marketed drugs and late-stage pipeline drugs, ...